Reply
J Allergy Clin Immunol
.
2017 May;139(5):1720-1721.
doi: 10.1016/j.jaci.2016.12.983.
Epub 2017 Mar 16.
Authors
Kusumam Joseph
1
,
Rosemeire N Constantino-Silva
2
,
Anete S Grumach
2
,
Anna Feldweg
3
,
Lakiea Wright
3
,
Natasha Frank
3
,
Dana Vuzman
3
,
Rohit Sharma
3
,
Chiara Suffritti
4
,
Marco Cicardi
4
,
Lilian Varga
5
,
Henriette Farkas
5
,
Konrad Bork
6
,
Allen P Kaplan
7
Affiliations
1
Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC. Electronic address: josephk@musc.edu.
2
Clinical Immunology, Faculty of Medicine ABC, Santo Andre, Sao Paulo, Brazil.
3
Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.
4
Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
5
Hungarian Angioedema Center, 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
6
Department of Dermatology, Johannes Gutenberg University, Mainz, Germany.
7
Department of Medicine, Medical University of South Carolina, Charleston, SC.
PMID:
28318557
DOI:
10.1016/j.jaci.2016.12.983
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Humans
Plasminogen Activator Inhibitor 2*
Substances
Plasminogen Activator Inhibitor 2